about
Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritisHow Rheumatoid Arthritis Can Result from Provocation of the Immune System by Microorganisms and VirusesHuman endogenous retrovirus group E and its involvement in diseasesAnti-endothelial cell antibodies in systemic sclerosisDNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus.Level of agreement between 2002 American-European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjögren's syndrome and reasons for discrepanciesEpigenetics and autoimmune diseases: the X chromosome-nucleolus nexusRecent progress in the understanding of B-cell functions in autoimmunity.Consequences of Fc gamma receptor type III reactivity in non-organ-specific autoimmune diseases.Autoantibodies to heparan sulfate proteoglycans.Antiendothelial cell antibodies in systemic lupus erythematosus.Pathogenic effects of anti-Fc gamma receptor IIIb (CD16) on polymorphonuclear neutrophils in non-organ-specific autoimmune diseases.Diagnostic and pathogenic implications of the heterogeneity of antiendothelial cell antibodies.The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases.Dysfunctional B cells in systemic lupus erythematosus.An in silico Approach Reveals Associations between Genetic and Epigenetic Factors within Regulatory Elements in B Cells from Primary Sjögren's Syndrome Patients.Rheumatoid factor on a daily basis.B lymphocytes are required for development and treatment of autoimmune diseases.Effects of anti-endothelial cell antibodies in leprosy and malariaB lymphocytes on the front line of autoimmunity.Endothelium, a target for immune-mediated assault in connective tissue disease.Anti-alpha-actinin antibodies: a new marker of lupus nephritis.The paradox of CD5-expressing B cells in systemic lupus erythematosus.Renal involvement in Wegener's granulomatosis.Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.B lymphocyte cytokines and rheumatic autoimmune disease.Monoclonal anti-CD20 antibodies: mechanisms of action and monitoring of biological effects.Autoreactive B cells and epigenetics.Epigenetics and autoimmunity.Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren's syndromeThe contribution of epigenetics in Sjögren's Syndrome.Glomerular antibodies in lupus nephritis.Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium.CD5 expression in B cells from patients with systemic lupus erythematosus.Epigenetics and autoimmunity, with special emphasis on methylation.DNA methylation and B-cell autoreactivity.Epigenetics and Sjögren's syndrome.CD5 expression promotes multiple intracellular signaling pathways in B lymphocyte.Altered patterns of epigenetic changes in systemic lupus erythematosus and auto-antibody production: is there a link?Aberrant B-lymphocyte responses in lupus: inherent or induced and potential therapeutic targets.
P50
Q26991887-257C5026-9C5B-4372-9E8A-427794578BBAQ27468876-E0062A45-1A3B-4CAB-9723-70AC33E731B1Q28082853-AB1DECE8-DE7F-4412-8017-A4E843A665CAQ33538934-ABBF6403-AECA-4A18-BBCC-AA759C3762B1Q33664826-CD424F93-1165-4EBF-9BB3-80C95014E6A6Q33765732-C72219FB-8786-4C50-8A15-21017E99B101Q34043443-F3D530DC-26D6-47DF-A303-3D0281EE678BQ34299834-42190055-8F15-4F3B-AC6B-3CFD99C374E4Q34797822-CB83EEC0-2233-4A18-891D-30AEC9C6AB7DQ35172070-6D436A06-6112-4F0D-AD39-EBB613EF2A85Q35172099-422FF8E6-BD6A-4709-925F-31CEE35F199DQ35172180-9D4ACDEA-E0B1-4ABD-90D2-60550B503AE2Q35862331-E4727CAB-DDF7-41C7-9857-288939993445Q35928662-D6568DF3-A171-4D18-94C0-A992D90EFEFAQ35952042-0C97D12A-E452-4550-9EFA-B9EFC88206B4Q35996410-87DAE00F-5C3E-4047-9ED1-B7CC4FA301B7Q36086125-B9D4A931-3B1F-447B-9378-27EC9170B754Q36193048-2E51A7E1-0992-4CFE-BDF3-CFBA795DA029Q36229121-3A99686C-825F-438E-8844-B01B7CE4C7BFQ36399123-BBCDD2CD-8C21-465D-9779-CEBC750D3164Q36399128-12F6862A-16EF-47CC-BA96-4190A80576D7Q36888138-A95418D4-BE3F-4AE5-9DE3-2F620E3003DCQ37012556-875B9768-BA98-4428-83B0-DAF93BF643D8Q37049170-9F0105F8-4F86-4759-9FD9-1DE5947AE7C0Q37156399-49D72C24-6798-4F82-80EB-1700608CE42AQ37535716-0071E0DA-4AD2-43D6-9E1C-F182875337D3Q37565888-10C63412-B86D-4DB7-8158-D0E655D91304Q37567567-2405AF1C-5A82-40C6-BF1B-80AFF58481CBQ37669513-57D39037-041B-4739-80C0-FC850C038E54Q37689729-C2F6072E-858C-4B1C-8F0F-74D18C74CF5CQ37695272-381D88DD-5EE3-433F-AA6F-B29347475237Q37736310-604C68BC-8084-491F-B441-A22937818407Q37746114-DB874D97-DEB1-4772-89A2-FA94798E0818Q37852012-43974210-941D-47F5-A503-51A89E8DCE8DQ37860845-7CADF5CD-CCF6-4D5C-BBC0-749B39A70A45Q37882656-DEEFA51E-2997-4CA9-AFB2-9377611DD819Q37972346-C1C5F173-58DA-4D0E-B46C-DEEA31B3C047Q37986380-D3792074-A7F2-4BE0-BD12-853DDE036016Q38019663-B87A1509-AD11-43BE-A536-A846B3CC5E35Q38108851-13C3649C-36E5-4FFD-B125-1AD49F38E5C4
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Yves Renaudineau
@ast
Yves Renaudineau
@en
Yves Renaudineau
@es
Yves Renaudineau
@nl
Yves Renaudineau
@sl
type
label
Yves Renaudineau
@ast
Yves Renaudineau
@en
Yves Renaudineau
@es
Yves Renaudineau
@nl
Yves Renaudineau
@sl
prefLabel
Yves Renaudineau
@ast
Yves Renaudineau
@en
Yves Renaudineau
@es
Yves Renaudineau
@nl
Yves Renaudineau
@sl
P214
P1053
K-5191-2013
P106
P1153
6701653641
P21
P213
0000 0001 4091 1982
P214
P2798
P31
P3829
P4450
yves-renaudineau
P496
0000-0001-5098-5002
P735
P7859
viaf-198794149